Status:

TERMINATED

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

Lead Sponsor:

Third People's Hospital, Huzhou City, Zhejiang Province, China

Conditions:

Schizophrenia Disorders

Cognitive Impairment

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

ACT combined with stratified intervention improved cognitive function and quality of life in elderly schizophrenia patients by enhancing psychological flexibility and family support.

Detailed Description

This study analyzes factors influencing cognitive impairment and evaluates the efficacy of a stratified intervention combining Acceptance and Commitment Therapy (ACT) with these factors to improve cog...

Eligibility Criteria

Inclusion

  • (1)Meets the diagnostic criteria for schizophrenia as defined in the International Classification of Diseases, Tenth Revision (ICD-10);
  • (2) age \> 60 years;
  • (3)possesses at least a primary school education, enabling independent completion of all questionnaires;
  • (4) has been taking antipsychotic medication continuously and regularly for at least one year during the enrollment period, with current symptoms and disease status stabilized in the maintenance phase;
  • (5)informed consent obtained from the patient or their family/guardian.

Exclusion

  • (1) Coexisting organic mental disorders, affective disorders, or similar conditions;
  • (2) coexisting physical illnesses that may affect cognitive function, such as hepatic or renal dysfunction;
  • (3) alcohol dependence or dependence on psychoactive substances;
  • (4) receipt of electroconvulsive therapy within the past three months.

Key Trial Info

Start Date :

October 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 19 2024

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT06949657

Start Date

October 13 2023

End Date

September 19 2024

Last Update

June 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Huzhou Third People's Hospital

Huzhou, China, 313000

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and | DecenTrialz